FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.66 EUR | +1.24% |
|
+1.61% | +4.56% |
| Jun. 05 | Dpa-AFX Overview: COMPANIES from 05.06.2024 - 15:15 | DP |
| Jun. 05 | Fresenius raises targets for hospital business - shares up | DP |
| Sales 2024 * | 19.56B 21.27B | Sales 2025 * | 20.3B 22.08B | Capitalization | 11.49B 12.5B |
|---|---|---|---|---|---|
| Net income 2024 * | 665M 723M | Net income 2025 * | 964M 1.05B | EV / Sales 2024 * | 1.09 x |
| Net Debt 2024 * | 9.86B 10.72B | Net Debt 2025 * | 8.99B 9.77B | EV / Sales 2025 * | 1.01 x |
| P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
11.9
x | Employees | 117,128 |
| Yield 2024 * |
2.7% | Yield 2025 * |
3.35% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | +0.18% | ||
| 1 week | +0.44% | ||
| Current month | +0.13% | ||
| 1 month | -0.96% | ||
| 3 months | +5.97% | ||
| 6 months | +5.09% | ||
| Current year | +3.35% |
1 week
38.85
39.86
1 month
36.5742.12
Current year
33.8842.12
1 year
30.1649.62
3 years
25.9571.14
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-06 | 39.66 | +1.25% | 35 099 |
| 24-06-05 | 39.17 | +0.08% | 270,917 |
| 24-06-04 | 39.14 | -0.28% | 288,100 |
| 24-06-03 | 39.25 | +0.18% | 259,310 |
| 24-05-31 | 39.18 | +0.31% | 828,830 |
Delayed Quote Xetra, June 06, 2024 at 04:57 am EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-07-29
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.17
EUR
Average target price
39.97
EUR
Spread / Average Target
+2.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.35% | 12.49B | |
| +24.47% | 88.24B | |
| -23.13% | 76.2B | |
| +1.34% | 26.63B | |
| +8.09% | 18.14B | |
| -12.89% | 16.69B | |
| +3.49% | 15.85B | |
| +76.87% | 13.61B | |
| +79.38% | 13.24B | |
| +38.44% | 12.72B |
- Stock Market
- Equities
- FME Stock
